靶向治疗药物-话题@MedSci

#靶向治疗药物#

12篇内容 | 546人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2060430, encodeId=7be4206043088, content=<a href='/topic/show?id=ba54999214e' target=_blank style='color:#2F92EE;'>#靶向治疗药物#</a>, objectTitle=全球硬皮病相关间质性肺疾病靶向治疗药物在华上市，可延缓肺部疾病进展, objectType=article, longId=200335, objectId=dbe02003355f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbe02003355f, replyNumber=0, likeNumber=42, createdTime=2021-04-13, rootId=0, userName=baoya, userId=743d308, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbe02003355f, moduleTitle=全球硬皮病相关间质性肺疾病靶向治疗药物在华上市，可延缓肺部疾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbe02003355f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2060427, encodeId=ed3f206042e45, content=<a href='/topic/show?id=ba54999214e' target=_blank style='color:#2F92EE;'>#靶向治疗药物#</a>, objectTitle=鼻息肉靶向治疗药物研究成功：IL-5单抗mepolizumab的III期研究效果显著（SYNAPSE研究）, objectType=article, longId=191428, objectId=b8ab191428cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8ab191428cc, replyNumber=0, likeNumber=48, createdTime=2020-04-30, rootId=0, userName=baoya, userId=743d308, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8ab191428cc, moduleTitle=鼻息肉靶向治疗药物研究成功：IL-5单抗mepolizumab的III期研究效果显著（SYNAPSE研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8ab191428cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2060429, encodeId=1585206042995, content=<a href='/topic/show?id=ba54999214e' target=_blank style='color:#2F92EE;'>#靶向治疗药物#</a>, objectTitle=NMPA：多发性硬化的S1P靶向治疗药物西尼莫德批准上市, objectType=article, longId=194138, objectId=e8bf19413837, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8bf19413837, replyNumber=0, likeNumber=0, createdTime=2020-06-09, rootId=0, userName=baoya, userId=743d308, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8bf19413837, moduleTitle=NMPA：多发性硬化的S1P靶向治疗药物西尼莫德批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8bf19413837)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2060428, encodeId=86f8206042813, content=<a href='/topic/show?id=ba54999214e' target=_blank style='color:#2F92EE;'>#靶向治疗药物#</a>, objectTitle=**胆管癌靶向治疗药物获得美国FDA批准！, objectType=article, longId=192585, objectId=36c019258504, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36c019258504, replyNumber=0, likeNumber=38, createdTime=2020-05-22, rootId=0, userName=baoya, userId=743d308, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36c019258504, moduleTitle=**胆管癌靶向治疗药物获得美国FDA批准！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36c019258504)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2060426, encodeId=18a22060426ea, content=<a href='/topic/show?id=ba54999214e' target=_blank style='color:#2F92EE;'>#靶向治疗药物#</a>, objectTitle=中国乳腺癌靶向治疗药物安全性管理专家共识, objectType=article, longId=186230, objectId=e591186230cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e591186230cb, replyNumber=0, likeNumber=33, createdTime=2020-10-24, rootId=0, userName=baoya, userId=743d308, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e591186230cb, moduleTitle=中国乳腺癌靶向治疗药物安全性管理专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e591186230cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2060425, encodeId=5a7420604251c, content=<a href='/topic/show?id=ba54999214e' target=_blank style='color:#2F92EE;'>#靶向治疗药物#</a>, objectTitle=强生的膀胱癌靶向治疗药物Balversa在美国获批, objectType=article, longId=164357, objectId=a0b416435e0c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0b416435e0c, replyNumber=0, likeNumber=34, createdTime=2019-07-15, rootId=0, userName=baoya, userId=743d308, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0b416435e0c, moduleTitle=强生的膀胱癌靶向治疗药物Balversa在美国获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0b416435e0c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2060424, encodeId=a85e206042463, content=<a href='/topic/show?id=ba54999214e' target=_blank style='color:#2F92EE;'>#靶向治疗药物#</a>, objectTitle=转移性膀胱癌的**靶向治疗药物：Balversa（erdafitinib）在美国加速获批, objectType=article, longId=164214, objectId=c97916421410, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c97916421410, replyNumber=0, likeNumber=31, createdTime=2019-05-27, rootId=0, userName=baoya, userId=743d308, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c97916421410, moduleTitle=转移性膀胱癌的**靶向治疗药物：Balversa（erdafitinib）在美国加速获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c97916421410)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2060423, encodeId=e33c2060423e6, content=<a href='/topic/show?id=ba54999214e' target=_blank style='color:#2F92EE;'>#靶向治疗药物#</a>, objectTitle=“四大”白血病靶向治疗药物盘点（上）, objectType=article, longId=146387, objectId=fa1814638e0c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa1814638e0c, replyNumber=0, likeNumber=45, createdTime=2019-01-18, rootId=0, userName=baoya, userId=743d308, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa1814638e0c, moduleTitle=“四大”白血病靶向治疗药物盘点（上）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa1814638e0c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2060422, encodeId=4e512060422fe, content=<a href='/topic/show?id=ba54999214e' target=_blank style='color:#2F92EE;'>#靶向治疗药物#</a>, objectTitle=FDA批准AML新靶向治疗药物, objectType=article, longId=107512, objectId=441a10e512b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=441a10e512b8, replyNumber=0, likeNumber=39, createdTime=2017-09-30, rootId=0, userName=baoya, userId=743d308, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=441a10e512b8, moduleTitle=FDA批准AML新靶向治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=441a10e512b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2060421, encodeId=dd0a206042128, content=<a href='/topic/show?id=ba54999214e' target=_blank style='color:#2F92EE;'>#靶向治疗药物#</a>, objectTitle=个性化医疗时代的双生花：伴随诊断和靶向治疗药物, objectType=article, longId=91996, objectId=7bf59199684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bf59199684, replyNumber=0, likeNumber=39, createdTime=2017-10-26, rootId=0, userName=baoya, userId=743d308, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bf59199684, moduleTitle=个性化医疗时代的双生花：伴随诊断和靶向治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bf59199684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2060420, encodeId=d88f206042052, content=<a href='/topic/show?id=ba54999214e' target=_blank style='color:#2F92EE;'>#靶向治疗药物#</a>, objectTitle=JCO：慢性淋巴细胞性白血病患者口服靶向治疗药物的经济负担研究, objectType=article, longId=83024, objectId=ed04830241f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed04830241f, replyNumber=0, likeNumber=34, createdTime=2017-02-09, rootId=0, userName=baoya, userId=743d308, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed04830241f, moduleTitle=JCO：慢性淋巴细胞性白血病患者口服靶向治疗药物的经济负担研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed04830241f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2060419, encodeId=af47206041974, content=<a href='/topic/show?id=ba54999214e' target=_blank style='color:#2F92EE;'>#靶向治疗药物#</a>, objectTitle=肿瘤分子靶向治疗药物研究进展, objectType=article, longId=3390, objectId=a1bb339089, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1bb339089, replyNumber=0, likeNumber=32, createdTime=2012-03-12, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1bb339089, moduleTitle=肿瘤分子靶向治疗药物研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1bb339089)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

靶向治疗药物

2020-05-29

baoya (审核中...)

前往app查看评论内容

#靶向治疗药物#

全球硬皮病相关间质性肺疾病靶向治疗药物在华上市，可延缓肺部疾病进展

2021-04-13

baoya (审核中...)

前往app查看评论内容

#靶向治疗药物#

鼻息肉靶向治疗药物研究成功：IL-5单抗mepolizumab的III期研究效果显著（SYNAPSE研究）

2020-04-30

baoya (审核中...)

前往app查看评论内容

#靶向治疗药物#

NMPA：多发性硬化的S1P靶向治疗药物西尼莫德批准上市

2020-06-09

baoya (审核中...)

前往app查看评论内容

#靶向治疗药物#

**胆管癌靶向治疗药物获得美国FDA批准！

2020-05-22

baoya (审核中...)

前往app查看评论内容

#靶向治疗药物#

中国乳腺癌靶向治疗药物安全性管理专家共识

2020-10-24

baoya (审核中...)

前往app查看评论内容

#靶向治疗药物#

强生的膀胱癌靶向治疗药物Balversa在美国获批

2019-07-15

baoya (审核中...)

前往app查看评论内容

#靶向治疗药物#

转移性膀胱癌的**靶向治疗药物：Balversa（erdafitinib）在美国加速获批

2019-05-27

baoya (审核中...)

前往app查看评论内容

#靶向治疗药物#

“四大”白血病靶向治疗药物盘点（上）

2019-01-18

baoya (审核中...)

前往app查看评论内容

#靶向治疗药物#

FDA批准AML新靶向治疗药物

2017-09-30

baoya (审核中...)

前往app查看评论内容

#靶向治疗药物#

个性化医疗时代的双生花：伴随诊断和靶向治疗药物

2017-10-26

baoya (审核中...)

前往app查看评论内容

#靶向治疗药物#

JCO：慢性淋巴细胞性白血病患者口服靶向治疗药物的经济负担研究

2017-02-09

heli0118 (审核中...)

前往app查看评论内容

#靶向治疗药物#

肿瘤分子靶向治疗药物研究进展

2012-03-12

科室
- - 订阅+
  - 更多科室
工具
服务